Web Stats Provided By Google Analytics

The Raw Stem Cell News Feed

The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research

Monday, March 9, 2015

Regeneus (ASX:RGS) Positive Preclinical Results For Progenza

The results showed no Progenza-related safety or toxicity issues, even at doses well in excess of the intended human dose. Further, Progenza-treated knees showed no deterioration from the time of injection, in contrast to the vehicle control group, which continued to deteriorate over the 7-week study.


No comments:

Post a Comment

Popular Stem Cell Roundup Posts